亚太药业 (002370.SZ) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 4.06B

MomentumView details →

1D Return

−3.71%

YTD Return

−26.27%

RSI (14)

46.1

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

—

Market Cap

CNY 4.06B

RSI (14)

46.1

MomentumView details →

1D Return

−3.71%

YTD Return

−26.27%

ProfitabilityView details →

Gross Margin

33.93%

Net Margin

31.91%

EBITDA Margin

38.43%

ROE (TTM)

9.08%

ROA (TTM)

8.23%

Asset Turnover

0.25x

GrowthView details →

Revenue YoY

−10.88%

EPS YoY

+196.07%

FCF YoY

−59.34%

Revenue CAGR 3Y

−4.71%

EPS CAGR 3Y

+160.00%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

—

Current Ratio

7.91x

Quick Ratio

6.98x

Div Yield

—

Div Rate

—

Div Growth 1Y

−50.00%

Financials snapshotView financials →

Revenue (TTM)

318.16M

Net Income (TTM)

101.52M

Op. CF (TTM)

15.12M

Latest newsMore news →

Zhuang Wei transferred his 39.96% partnership interest in Zhejiang Xinghao Holding Partnership to Qiu Zhongxun, and the business registration change has been completed.3d ago

Yatai Pharmaceutical's wholly-owned subsidiary Zhejiang Yatai Lizhong Holding Co., Ltd. and Meiruida Health Investment (Wuhan) Partnership (Limited Partnership) jointly invested to establish Zhejiang Xingcui Biotechnology Co., Ltd., with a registered capital of 20 million yuan and legal representative Cheng Nana.18d ago

Similar companies

博汇股份300839.SZ 立高食品300973.SZ 中船汉光300847.SZ 耐普矿机300818.SZ 金陵药业000919.SZ 长联科技301618.SZ Find similar companies →

Latest newsMore news →

Zhuang Wei transferred his 39.96% partnership interest in Zhejiang Xinghao Holding Partnership to Qiu Zhongxun, and the business registration change has been completed.3d ago Yatai Pharmaceutical's wholly-owned subsidiary Zhejiang Yatai Lizhong Holding Co., Ltd. and Meiruida Health Investment (Wuhan) Partnership (Limited Partnership) jointly invested to establish Zhejiang Xingcui Biotechnology Co., Ltd., with a registered capital of 20 million yuan and legal representative Cheng Nana.18d ago